Patent · US Active

Viral polymerase inhibitors

US8546389B2 · kind B2 · utility

2Cited by
2References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 20, 2011
Grant dateOct 1, 2013
Priority date
Expiry dateOct 20, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to viral polymerase inhibitors of formula (I), salts, N-oxides, solvates, hydrates, racemates, enantiomers or isomers thereof, processes for their preparation and their use in the treatment of Flaviviridae viral infections such as Hepatitis C virus (HCV) infections:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.